Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Pharma Equity Group A/S
CSE:PEG

Watchlist Manager
Pharma Equity Group A/S Logo
Pharma Equity Group A/S
CSE:PEG
Watchlist
Price: 0.107 DKK 5.42% Market Closed
Market Cap: kr131.3m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-8%
5Y
-14%
10Y
-50%
Liabilities
+
3Y
-1%
5Y
+34%
10Y
-17%
Equity
+
3Y
-11%
5Y
-29%
10Y
-59%

Balance Sheet Decomposition
Pharma Equity Group A/S

Balance Sheet
Pharma Equity Group A/S

Rotate your device to view
Balance Sheet
Currency: DKK
Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
4
1
0
1
1
9
8
4
3
54
21
0
0
0
0
0
0
0
0
0
4
4
Cash Equivalents
4
1
0
1
1
9
8
4
3
54
21
0
0
0
0
0
0
0
0
0
4
4
Short-Term Investments
395
489
424
429
443
200
0
0
0
0
0
0
2
1
0
2
0
0
0
0
0
0
Total Receivables
64
63
40
18
11
4
0
3
1
1
21
1
1
0
12
8
1
0
0
0
63
60
Accounts Receivables
64
63
40
18
11
4
0
3
1
1
21
1
1
0
0
8
1
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
53
35
35
35
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
44
0
3
0
0
124
75
0
71
0
0
71
0
1
Total Current Assets
463
554
465
448
455
213
61
42
82
89
45
1
3
126
86
9
72
0
0
71
67
65
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
100
100
0
0
0
0
0
0
0
1
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
72
0
58
64
0
0
0
Long-Term Investments
0
81
117
147
133
35
0
438
403
397
206
24
24
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
2
2
3
13
15
17
22
17
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
463
N/A
634
+37%
584
-8%
597
+2%
591
-1%
262
-56%
76
-71%
497
+557%
508
+2%
504
-1%
251
-50%
124
-51%
126
+2%
126
0%
86
-31%
81
-6%
72
-10%
58
-20%
64
+10%
71
+12%
68
-5%
66
-3%
Liabilities
Accounts Payable
67
63
5
16
2
1
12
6
58
17
26
3
4
2
1
2
4
3
1
2
10
4
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
155
1
1
2
0
1
1
2
3
5
4
1
Current Portion of Long-Term Debt
0
0
0
433
440
205
0
0
0
6
18
0
5
6
0
0
0
9
9
18
0
0
Other Current Liabilities
1
1
0
0
0
0
0
5
44
5
8
0
0
20
0
0
1
10
2
0
20
3
Total Current Liabilities
68
63
5
449
442
205
12
11
102
28
206
4
10
29
1
3
5
23
15
25
34
9
Long-Term Debt
290
430
430
0
0
0
10
241
324
378
150
0
0
0
0
0
0
0
7
0
8
8
Deferred Income Tax
2
0
0
0
0
0
0
2
2
11
0
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
7
0
0
0
0
0
5
4
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
190
0
51
0
22
17
0
0
0
0
0
0
0
0
0
Total Liabilities
360
N/A
493
+37%
435
-12%
449
+3%
442
-1%
205
-54%
29
-86%
444
+1 437%
428
-4%
468
+9%
357
-24%
26
-93%
31
+19%
33
+4%
1
-96%
3
+175%
5
+58%
23
+348%
21
-9%
25
+18%
42
+70%
17
-61%
Equity
Common Stock
98
131
122
131
123
123
131
45
76
76
76
109
109
109
119
119
83
83
19
19
1 023
123
Retained Earnings
5
10
26
25
26
66
84
8
4
39
181
11
14
15
34
42
16
49
24
27
0
0
Additional Paid In Capital
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
8
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
998
74
Total Equity
103
N/A
141
+36%
149
+5%
148
0%
149
+1%
56
-62%
47
-17%
53
+13%
80
+50%
36
-54%
105
N/A
98
N/A
95
-3%
93
-2%
85
-9%
78
-9%
67
-13%
34
-49%
43
+24%
46
+8%
25
-45%
49
+93%
Total Liabilities & Equity
463
N/A
634
+37%
584
-8%
597
+2%
591
-1%
262
-56%
76
-71%
497
+557%
508
+2%
504
-1%
251
-50%
124
-51%
126
+2%
126
0%
86
-31%
81
-6%
72
-10%
58
-20%
64
+10%
71
+12%
68
-5%
66
-3%
Shares Outstanding
Common Shares Outstanding
1
1
1
1
1
1
1
1
2
2
1
14
14
14
16
16
26
29
33
33
1 023
1 228

See Also

Summary
PEG intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEG stock valuation using valuation multiples.
Wall Street Estimates
PEG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.